Skip to main content

Diabetes Care for People with Serious Mental Illness: Hemoglobin A1c (HbA1c) Control (<8.0%)

CBE ID
2608
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

The percentage of patients 18-75 years of age with a serious mental and diabetes (type 1 and type 2) whose most recent HbA1c level during the measurement year is <8.0%. 

Note: This measure is adapted from an existing health plan measure used in a variety of reporting programs for the general population (NQF #0575: Comprehensive Diabetes Care: Hemoglobin A1c (HbA1c) Control <8.0). This measure is endorsed by NQF and is currently stewarded by NCQA.

        • 1.14 Numerator

          Patients whose most recent HbA1c level was less than 8.0% during the measurement year. 

          The outcome is an out of range result of an HbA1c test, indicating good control of diabetes. Good control reduces the risk for complications including renal failure, blindness, and neurologic damage. There is no need for risk adjustment for this intermediate outcome measure.

        • 1.15 Denominator

          Patients 18-75 years as of December 31st of the measurement year with at least one acute inpatient visit or two outpatient visits for schizophrenia or bipolar I disorder, or at least one inpatient visit for major depression during the measurement year AND diagnosis of diabetes (type 1 and type 2) during the measurement year or the year before.

        • Exclusions

          Patients who do not have a diagnosis of diabetes and who had a diagnosis of gestational or steroid-induced diabetes.

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed Behavioral Health and Substance Use Fall Cycle 2019
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          National Committee for Quality Assurance
          Steward Organization POC Email
          Steward Organization Copyright

          © [2014] by the National Committee for Quality Assurance
          1100 13th Street, NW, Suite 1000
          Washington, DC 20005